BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Imai A, Mochizuki D, Misawa Y, Nakagawa T, Endo S, Mima M, Yamada S, Kawasaki H, Kanazawa T, Misawa K. SALL2 Is a Novel Prognostic Methylation Marker in Patients with Oral Squamous Carcinomas: Associations with SALL1 and SALL3 Methylation Status. DNA Cell Biol 2019;38:678-87. [PMID: 31188017 DOI: 10.1089/dna.2018.4597] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Zapata-García JA, Riveros-Magaña AR, Ortiz-Lazareno PC, Hernández-Flores G, Jave-Suárez LF, Aguilar-Lemarroy A. Comparative Genomic Hybridization and Transcriptome Sequencing Reveal Genes with Gain in Acute Lymphoblastic Leukemia: JUP Expression Emerges as a Survival-Related Gene. Diagnostics (Basel) 2022;12. [PMID: 36428851 DOI: 10.3390/diagnostics12112788] [Reference Citation Analysis]
2 Sun B, Xu L, Bi W, Ou W. SALL4 Oncogenic Function in Cancers: Mechanisms and Therapeutic Relevance. IJMS 2022;23:2053. [DOI: 10.3390/ijms23042053] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
3 Álvarez C, Quiroz A, Benítez-Riquelme D, Riffo E, Castro AF, Pincheira R. SALL Proteins; Common and Antagonistic Roles in Cancer. Cancers (Basel) 2021;13:6292. [PMID: 34944911 DOI: 10.3390/cancers13246292] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
4 Xu J, Yao Y, Xu B, Li Y, Su Z. Unsupervised learning of cross-modal mappings in multi-omics data for survival stratification of gastric cancer. Future Oncol 2022;18:215-30. [PMID: 34854737 DOI: 10.2217/fon-2021-1059] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Gougousis S, Mouchtaropoulou E, Besli I, Vrochidis P, Skoumpas I, Constantinidis I. HPV-Related Oropharyngeal Cancer and Biomarkers Based on Epigenetics and Microbiome Profile. Front Cell Dev Biol 2020;8:625330. [PMID: 33521000 DOI: 10.3389/fcell.2020.625330] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
6 Misawa K, Misawa Y, Mima M, Yamada S, Imai A, Mochizuki D, Nakagawa T, Kurokawa T, Endo S, Kawasaki H, Brenner JC, Mineta H. Overexpression of Sal-like protein 4 in head and neck cancer: epigenetic effects and clinical correlations. Cell Oncol (Dordr) 2020;43:631-41. [PMID: 32240499 DOI: 10.1007/s13402-020-00509-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
7 Misawa K, Mima M, Satoshi Y, Imai A, Mochizuki D, Ishikawa R, Kita J, Yamaguchi Y, Endo S, Misawa Y, Mineta H. Prostanoid receptor genes confer poor prognosis in head and neck squamous cell carcinoma via epigenetic inactivation. J Transl Med 2020;18:31. [PMID: 31969157 DOI: 10.1186/s12967-020-02214-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
8 Ye L, Lin C, Wang X, Li Q, Li Y, Wang M, Zhao Z, Wu X, Shi D, Xiao Y, Ren L, Jian Y, Yang M, Ou R, Deng G, Ouyang Y, Chen X, Li J, Song L. Epigenetic silencing of SALL2 confers tamoxifen resistance in breast cancer. EMBO Mol Med 2019;11:e10638. [PMID: 31657150 DOI: 10.15252/emmm.201910638] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 7.5] [Reference Citation Analysis]